Your browser doesn't support javascript.
loading
Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells.
Hoefsmit, Esmée P; van Royen, Paula T; Rao, Disha; Stunnenberg, Johanna A; Dimitriadis, P; Lieftink, Cor; Morris, Ben; Rozeman, Elisa A; Reijers, Irene L M; Lacroix, Ruben; Shehwana, Huma; Ligtenberg, Maarten A; Beijersbergen, Roderick L; Peeper, Daniel S; Blank, Christian U.
Afiliação
  • Hoefsmit EP; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Royen PT; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Rao D; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Stunnenberg JA; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Dimitriadis P; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Lieftink C; Robotics and Screening Facility, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Morris B; Robotics and Screening Facility, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Rozeman EA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Reijers ILM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Lacroix R; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Shehwana H; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Ligtenberg MA; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Beijersbergen RL; Robotics and Screening Facility, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Peeper DS; Oncode Institute, the Netherlands.
  • Blank CU; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Cancer Immunol Res ; 11(4): 450-465, 2023 04 03.
Article em En | MEDLINE | ID: mdl-36753604

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apresentação Cruzada / Melanoma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Apresentação Cruzada / Melanoma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda